Vascular Endothelial Growth Factor Receptor 2 Expression and Immunotherapy Efficacy in Non-Small Cell Lung Cancer

Patients with advanced non-small cell lung cancer were treated with immune-checkpoint inhibitors. Scientists analyzed immune and tumor cell staining separately in order to determine their correlation with the objective response rate, progression-free survival and overall survival in patients receiving immune-checkpoint inhibitors.